LYNPARZA has been approved in Japan for the treatment of three types of advanced cancer: ovarian, prostate and pancreatic cancer.... Dec 28
If approved, Zeposia would be the first oral sphingosine-1-phosphate (S1P) receptor modulator for the treatment of ulcerative colitis.... Dec 28
Meloxicam Capsules is the generic equivalent of Vivlodex Capsules of Zyla Life Sciences US, Inc., and indicated for the management of osteoarthritis (OA) pain.... Dec 28
... Dec 24
... Dec 23
Tezepelumab’s effect on other efficacy parameters was similar to those observed in previous trials, including the registrational Phase III NAVIGATOR trial.... Dec 22
... Dec 22
Glenmark has received tentative approval by the United States Food & Drug Administration for Dabigatran Etexilate Capsules, the generic version of Pradaxa 1 Capsules... Dec 21
This authorization represents the first time people living with HIV in Europe may be able to receive a long-acting injectable treatment that removes the ... Dec 21
Approval based on unprecedented results from the ADAURA Phase III trial where Tagrisso reduced the risk of disease recurrence or death by 80%... Dec 21
Companies to commercialize margetuximab in the United States, if approved.... Dec 02
This will be a multicenter and randomized controlled study, which will include a safety and immunogenicity study.... Dec 02
LuminUltra increases testing capacity including the range of COVID-19 offerings with the acquisition ... Dec 02
Eprenetapopt indicated for the treatment of TP53 Mutant Acute Myeloid Leukemia (AML)... Dec 02
... Dec 02
-Advertisements-
.jpeg)
Sunday, April 06, 2025
.jpeg)
.jpeg)
.jpeg)
.jpeg)
